Javascript must be enabled to continue!
Eosinophils Maintain Their Capacity to Signal and Release Eosinophil Cationic Protein Upon Repetitive Stimulation with the Same Agonist
View through CrossRef
Abstract
Eosinophils contain in their granules eosinophil cationic protein (ECP) and other basic proteins that have been implicated in immunity to parasites and pathophysiology of chronic allergic responses. In a model of eosinophil degranulation, we show that eosinophils release ECP upon short-term GM-CSF priming and stimulation with either platelet-activating factor (PAF) or the anaphylatoxin C5a, but not eotaxin. Restimulation with the same agonist (PAF or C5a) was unsuccessful as assessed by monitoring intracellular calcium concentration and ECP release. In contrast, upon an intermediate washing step, eosinophils rapidly transduced PAF and C5a signals followed by significant ECP releases. Ligand-binding studies demonstrated that only a proportion of PAF receptors is internalized upon cell stimulation and that washing of the cells removes the agonist from the cell surface. Upon repetitive stimulation, eosinophils with less than 50% of the original ECP content were obtained. Such eosinophils did not increase cellular ECP levels even in the presence of the eosinophil survival factor GM-CSF in overnight cultures. In vivo studies revealed that eosinophils always express detectable amounts of ECP under chronic inflammatory conditions. In conclusion, we have shown that eosinophils maintain their capacity to degranulate upon repetitive stimulation with the same agonist as long as the receptor is not occupied from a previous stimulation. The cellular content of ECP appears to be a no limiting factor in the case of repetitive stimulation, implying that mature eosinophils may not require a significant ECP resynthesis.
Oxford University Press (OUP)
Title: Eosinophils Maintain Their Capacity to Signal and Release Eosinophil Cationic Protein Upon Repetitive Stimulation with the Same Agonist
Description:
Abstract
Eosinophils contain in their granules eosinophil cationic protein (ECP) and other basic proteins that have been implicated in immunity to parasites and pathophysiology of chronic allergic responses.
In a model of eosinophil degranulation, we show that eosinophils release ECP upon short-term GM-CSF priming and stimulation with either platelet-activating factor (PAF) or the anaphylatoxin C5a, but not eotaxin.
Restimulation with the same agonist (PAF or C5a) was unsuccessful as assessed by monitoring intracellular calcium concentration and ECP release.
In contrast, upon an intermediate washing step, eosinophils rapidly transduced PAF and C5a signals followed by significant ECP releases.
Ligand-binding studies demonstrated that only a proportion of PAF receptors is internalized upon cell stimulation and that washing of the cells removes the agonist from the cell surface.
Upon repetitive stimulation, eosinophils with less than 50% of the original ECP content were obtained.
Such eosinophils did not increase cellular ECP levels even in the presence of the eosinophil survival factor GM-CSF in overnight cultures.
In vivo studies revealed that eosinophils always express detectable amounts of ECP under chronic inflammatory conditions.
In conclusion, we have shown that eosinophils maintain their capacity to degranulate upon repetitive stimulation with the same agonist as long as the receptor is not occupied from a previous stimulation.
The cellular content of ECP appears to be a no limiting factor in the case of repetitive stimulation, implying that mature eosinophils may not require a significant ECP resynthesis.
Related Results
Objective markers of allergic inflammation
Objective markers of allergic inflammation
Introduction: According to the results of modern research, allergic rhinitis (AR) affects 10% to 40% of the population. There is a need for an effective objective and dynamic metho...
TNFα‐induced activation of eosinophil oxidative metabolism and morphology ‐ Comparison with IL‐5*
TNFα‐induced activation of eosinophil oxidative metabolism and morphology ‐ Comparison with IL‐5*
Abstract Human dermal mast cells are capable of releasing cytokines, particularly preformed TNFα, upon appropriate stimulation. Masl cell activation in vivo was shown to be associa...
2B4 (CD244) Is Expressed and Functional on Human Eosinophils
2B4 (CD244) Is Expressed and Functional on Human Eosinophils
Abstract
Eosinophils are present in parasitic, allergic, various immunological, and malignant disorders as well as in a variety of idiopathic hypereosinophilic sy...
Rapid GPR183-mediated recruitment of eosinophils to the lung after
Mycobacterium tuberculosis
infection
Rapid GPR183-mediated recruitment of eosinophils to the lung after
Mycobacterium tuberculosis
infection
SUMMARY
Influx of eosinophils into the lungs is typically associated with type-II responses during allergy, fungal and parasitic infections. Howe...
The eosinophil and the eye
The eosinophil and the eye
Personal studies in allergic eye diseases reviewed in this paper indicate that: 1. An increased number and an abnormal distribution of eosinophils is present in conjunctival biopsi...
Anti‐apoptotic signals of granulocyte‐macrophage colony‐stimulating factor are transduced via Jak2 tyrosine kinase in eosinophils
Anti‐apoptotic signals of granulocyte‐macrophage colony‐stimulating factor are transduced via Jak2 tyrosine kinase in eosinophils
AbstractCytokine‐mediated inhibition of eosinophil apoptosis is a mechanism causing tissue eosinophilia. Previously published work suggested that activation of the Lyn‐Ras‐Raf‐1‐MA...
Eosinophils and Bacteria, the Beginning of a Story
Eosinophils and Bacteria, the Beginning of a Story
Eosinophils are granulocytes primarily associated with TH2 responses to parasites or immune hyper-reactive states, such as asthma, allergies, or eosinophilic esophagitis. However, ...
Eosinophils are an endogenous source of IL-4 during filarial infections and contribute to the development of an optimal T helper 2 response
Eosinophils are an endogenous source of IL-4 during filarial infections and contribute to the development of an optimal T helper 2 response
ABSTRACTInterleukin-4 (IL-4) is a central regulator of type 2 immunity, crucial for the defense against multicellular parasites like helminths. This study focuses on its roles and ...

